Intensity Therapeutics Inc (INTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INTS | AZN | AMGN | GILD | BMY |
| Company | Intensity Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 6.92 | 206.74 | 381.50 | 147.35 | 61.50 |
| High | 7.23 | 207.55 | 387.49 | 149.11 | 62.12 |
| Low | 6.35 | 205.30 | 380.54 | 146.39 | 60.90 |
| Latest | 7.12 | 205.79 | 384.33 | 147.12 | 61.30 |
| Change | +0.32 | -0.82 | +1.46 | -0.52 | -0.30 |
| % Change | +4.71% | -0.40% | +0.38% | -0.35% | -0.49% |
| Volume | 110,342 | 1,432,054 | 2,454,247 | 6,206,647 | 15,130,781 |
| 20-Day Average Volume | 79,387 | 2,717,933 | 2,994,117 | 7,755,317 | 13,570,733 |
| Previous Close | 6.80 | 206.61 | 382.87 | 147.64 | 61.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.00 | 197.10 | 366.05 | 148.61 | 59.12 |
| 20-Day Raw Stochastic | 39.43% | 76.20% | 93.61% | 46.64% | 89.63% |
| 20-Day Relative Strength | 42.30 | 62.23 | 65.73 | 57.80 | 65.07 |
| Weighted Alpha | -79.93 | +44.43 | +35.09 | +37.78 | +16.98 |
| Today's Opinion | 56% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 96% Buy | 88% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.20% since 02/18/26 | -1.38% since 02/18/26 | +1.21% since 02/18/26 | -3.68% since 02/18/26 | +2.63% since 02/18/26 |
| Low | 5.40 on 02/19/26 | 204.05 on 02/20/26 | 371.39 on 02/20/26 | 146.39 on 02/25/26 | 59.23 on 02/19/26 |
| High | 7.23 on 02/25/26 | 209.35 on 02/24/26 | 387.49 on 02/25/26 | 153.26 on 02/20/26 | 62.12 on 02/25/26 |
| 1-Month | |||||
| %Chg | -28.12% since 01/23/26 | +10.70% since 01/23/26 | +11.48% since 01/23/26 | +8.23% since 01/23/26 | +12.17% since 01/23/26 |
| Low | 5.40 on 02/19/26 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 133.69 on 01/26/26 | 54.21 on 01/29/26 |
| High | 10.24 on 01/27/26 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| 3-Month | |||||
| %Chg | -27.99% since 11/25/25 | +10.35% since 11/25/25 | +12.67% since 11/25/25 | +15.73% since 11/25/25 | +24.97% since 11/25/25 |
| Low | 5.40 on 02/19/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 15.00 on 12/12/25 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| 6-Month | |||||
| %Chg | -8.69% since 08/25/25 | +29.17% since 08/25/25 | +33.23% since 08/25/25 | +28.88% since 08/25/25 | +30.04% since 08/25/25 |
| Low | 5.39 on 09/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 43.50 on 10/30/25 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,231 | 320,433,088 | 206,392,960 | 183,174,000 | 125,446,800 |
| Shares Outstanding, K | 2,534 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -16,270,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,670,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 3.57 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/12/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.30 | 17.36 | 18.38 | 9.96 |